1. Home
  2. HCAT vs THRD Comparison

HCAT vs THRD Comparison

Compare HCAT & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCAT
  • THRD
  • Stock Information
  • Founded
  • HCAT 2008
  • THRD 2019
  • Country
  • HCAT United States
  • THRD United States
  • Employees
  • HCAT N/A
  • THRD N/A
  • Industry
  • HCAT Computer Software: Programming Data Processing
  • THRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCAT Technology
  • THRD Health Care
  • Exchange
  • HCAT Nasdaq
  • THRD Nasdaq
  • Market Cap
  • HCAT 334.1M
  • THRD 335.2M
  • IPO Year
  • HCAT 2019
  • THRD 2022
  • Fundamental
  • Price
  • HCAT $5.68
  • THRD $6.00
  • Analyst Decision
  • HCAT Buy
  • THRD Strong Buy
  • Analyst Count
  • HCAT 11
  • THRD 3
  • Target Price
  • HCAT $10.91
  • THRD $20.33
  • AVG Volume (30 Days)
  • HCAT 732.9K
  • THRD 248.2K
  • Earning Date
  • HCAT 02-20-2025
  • THRD 11-07-2024
  • Dividend Yield
  • HCAT N/A
  • THRD N/A
  • EPS Growth
  • HCAT N/A
  • THRD N/A
  • EPS
  • HCAT N/A
  • THRD N/A
  • Revenue
  • HCAT $302,062,000.00
  • THRD N/A
  • Revenue This Year
  • HCAT $5.83
  • THRD N/A
  • Revenue Next Year
  • HCAT $10.50
  • THRD N/A
  • P/E Ratio
  • HCAT N/A
  • THRD N/A
  • Revenue Growth
  • HCAT 4.15
  • THRD N/A
  • 52 Week Low
  • HCAT $5.35
  • THRD $5.60
  • 52 Week High
  • HCAT $10.99
  • THRD $16.94
  • Technical
  • Relative Strength Index (RSI)
  • HCAT 29.94
  • THRD 23.75
  • Support Level
  • HCAT $5.35
  • THRD $5.60
  • Resistance Level
  • HCAT $7.65
  • THRD $11.78
  • Average True Range (ATR)
  • HCAT 0.47
  • THRD 0.89
  • MACD
  • HCAT -0.14
  • THRD -0.43
  • Stochastic Oscillator
  • HCAT 14.35
  • THRD 6.50

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Share on Social Networks: